Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors
Neurotensin receptor 1 (NTS1) is overexpressed on a variety of cancer entities; for example, prostate cancer, ductal pancreatic adenocarcinoma, and breast cancer. Therefore, it represents an interesting target for the diagnosis of these cancers types by positron emission tomography (PET) [...]
Main Authors: | Simone Maschauer, Jürgen Einsiedel, Dominik Reich, Harald Hübner, Peter Gmeiner, Hans-Jürgen Wester, Olaf Prante, Johannes Notni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/10/1/29 |
Similar Items
-
In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by Small-Animal Positron Emission Tomography: A Pilot Study
by: Simone Maschauer, et al.
Published: (2014-04-01) -
Effect of neurotensin on cultured mouse preimplantation embryos
by: Yuki HIRADATE, et al.
Published: (2020-06-01) -
The role of Neurotensin and its receptors in non-gastrointestinal cancers: a review
by: Stella Nikolaou, et al.
Published: (2020-04-01) -
PET Imaging of the Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68
by: Hailey A. Houson, et al.
Published: (2022-12-01) -
Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment
by: Francisco D. Rodríguez, et al.
Published: (2023-05-01)